Barrett Elizabeth A.
Insider CIK 1764157 · SAGE Director · URGN Chief Executive Officer · ALLO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 95,400 | — | $0 | 95,400 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2026-01-31 | 2026-02-19 | 153,195 | — | $0 | 153,195 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 21,500 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | U Tender | 2025-07-31 | 2025-07-31 | 3,000 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2025-07-28 | 2025-07-30 | 87,615 | — | $0 | 87,615 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-06-18 | 2025-06-23 | 95,400 | — | $0 | 95,400 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 21,500 | — | $0 | 21,500 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2025-01-31 | 2025-02-04 | 96,377 | — | $0 | 96,377 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 191,082 | — | $0 | 191,082 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-01-31 | 2024-02-02 | 87,615 | — | $0 | 87,615 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-06-13 | 2023-06-15 | 116,120 | — | $0 | 116,120 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2023-01-31 | 2023-02-02 | 5,000 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2023-01-31 | 2023-02-02 | 13,333 | — | $0 | 13,334 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-01-31 | 2023-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-01-31 | 2023-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-01-31 | 2023-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2023-01-31 | 2023-02-02 | 5,000 | — | $0 | 313,358 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2023-01-31 | 2023-02-02 | 13,333 | — | $0 | 326,691 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-06-15 | 2022-06-17 | 71,070 | — | $0 | 71,070 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2022-01-31 | 2022-02-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-01-31 | 2022-02-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-01-31 | 2022-02-02 | 13,333 | — | $0 | 26,667 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-01-31 | 2022-02-02 | 13,333 | — | $0 | 314,318 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2022-01-31 | 2022-02-02 | 2,235 | $7.58 | $16.9K | 300,985 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-01-31 | 2022-02-02 | 5,000 | — | $0 | 303,220 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2022-01-31 | 2022-02-02 | 5,960 | $7.58 | $45.2K | 308,358 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2022-01-04 | 2022-01-07 | 46,968 | $9.15 | $429.8K | 298,220 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-01-03 | 2022-01-07 | 105,689 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-01-03 | 2022-01-07 | 105,689 | — | $0 | 345,188 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-07-30 | 2021-08-03 | 63,385 | — | $0 | 63,385 | SEC↗ |
| URGN UroGen Pharma Ltd. | F Tax w/h | 2021-05-19 | 2021-05-21 | 2,185 | $17.51 | $38.3K | 240,739 | SEC↗ |
| URGN UroGen Pharma Ltd. | F Tax w/h | 2021-05-19 | 2021-05-21 | 1,240 | $17.51 | $21.7K | 239,499 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2021-01-31 | 2021-05-21 | 5,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2021-01-31 | 2021-05-21 | 5,000 | — | $0 | 242,924 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-01-31 | 2021-02-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-01-31 | 2021-02-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2021-01-03 | 2021-05-21 | 8,807 | — | $0 | 105,689 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2021-01-03 | 2021-05-21 | 8,807 | — | $0 | 237,924 | SEC↗ |
| URGN UroGen Pharma Ltd. | P Buy | 2020-12-14 | 2020-12-15 | 10,000 | $18.50 | $185.0K | 229,117 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-12-04 | 2020-12-04 | 61,652 | — | $0 | 114,496 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-12-04 | 2020-12-04 | 61,652 | — | $0 | 219,117 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-12-03 | 2021-07-12 | 8,808 | — | $0 | 114,496 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-12-03 | 2021-07-12 | 8,808 | — | $0 | 219,117 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-11-03 | 2021-07-12 | 8,808 | — | $0 | 123,304 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-11-03 | 2021-07-12 | 8,808 | — | $0 | 210,309 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-10-03 | 2021-07-12 | 8,808 | — | $0 | 132,112 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-10-03 | 2021-07-12 | 8,808 | — | $0 | 201,501 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-09-03 | 2021-07-12 | 8,807 | — | $0 | 140,920 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-09-03 | 2021-07-12 | 8,807 | — | $0 | 192,693 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-08-03 | 2021-07-12 | 8,807 | — | $0 | 149,727 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-08-03 | 2021-07-12 | 8,807 | — | $0 | 183,886 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-07-03 | 2021-07-12 | 8,807 | — | $0 | 158,534 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-07-03 | 2021-07-12 | 8,807 | — | $0 | 175,079 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-06-03 | 2021-07-12 | 8,807 | — | $0 | 167,341 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-06-03 | 2021-07-12 | 8,807 | — | $0 | 166,272 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-05-12 | 2020-05-14 | 35,229 | — | $0 | 176,148 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-05-12 | 2020-05-14 | 35,229 | — | $0 | 157,465 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-05-03 | 2021-07-12 | 8,808 | — | $0 | 176,148 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-05-03 | 2021-07-12 | 8,808 | — | $0 | 157,465 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-04-03 | 2021-07-12 | 8,807 | — | $0 | 198,956 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-04-03 | 2021-07-12 | 8,807 | — | $0 | 148,657 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-03-03 | 2021-07-12 | 8,807 | — | $0 | 193,763 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-03-03 | 2021-07-12 | 8,807 | — | $0 | 139,850 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-02-03 | 2021-07-12 | 8,807 | — | $0 | 202,570 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-02-03 | 2021-07-12 | 8,807 | — | $0 | 131,043 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-01-31 | 2020-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-01-31 | 2020-02-04 | 45,000 | — | $0 | 45,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-01-03 | 2020-01-07 | 105,688 | — | $0 | 211,377 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-01-03 | 2020-01-07 | 105,688 | — | $0 | 122,236 | SEC↗ |
| URGN UroGen Pharma Ltd. | P Buy | 2019-11-21 | 2019-11-22 | 7,530 | $28.00 | $210.8K | 16,548 | SEC↗ |
| URGN UroGen Pharma Ltd. | P Buy | 2019-11-20 | 2019-11-22 | 7,470 | $28.00 | $209.2K | 9,018 | SEC↗ |
| URGN UroGen Pharma Ltd. | P Buy | 2019-11-15 | 2019-11-18 | 1,548 | $26.00 | $40.2K | 1,548 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2018-01-03 | 2019-01-09 | 317,065 | — | $0 | 317,065 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2018-01-03 | 2019-01-09 | 277,432 | — | $0 | 277,432 | SEC↗ |